Related Experiment Video
Updated: Sep 19, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Heart failure and co-morbidities confer a negative prognosis in COVID-19 infection
Antonio E Pontiroli1, Giuseppe Ambrosio2, Olivia Leoni3
1Università degli Studi di Milano, Dipartimento di Scienze della Salute, Milan, Italy.
Insights
Patients with heart failure (HF) had a significantly higher risk of COVID-19 infection, hospitalization, and mortality compared to those without HF. Age, male sex, and prior HF hospitalizations were key risk factors for adverse outcomes in HF patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Cardiovascular diseases, including heart failure (HF), are established risk factors for severe COVID-19 outcomes.
- The COVID-19 pandemic disproportionately affected regions like Lombardy, Italy.
- Understanding the specific impact on HF populations is crucial for public health strategies.
Purpose of the Study:
- To compare COVID-19 infection rates, hospital admissions, and mortality between patients with and without HF.
- To identify risk factors for COVID-19 infection and all-cause mortality among HF patients.
Main Methods:
- A large cohort study in the Lombardy Region, comparing 98,549 HF patients (2015-2019 discharges) with 394,104 randomly selected No-HF patients (>40 years).
- Analysis of laboratory-confirmed COVID-19 cases diagnosed from February 21 to October 1, 2020.
- Outcomes assessed included COVID-19 occurrence, hospitalization, and death.
Main Results:
- HF patients exhibited significantly higher incidence rates for COVID-19 infection (29.65 vs 10.20 per 100,000), hospitalization (14.97 vs 3.48 per 100,000), and mortality (5.37 vs 0.57 per 100,000) compared to No-HF patients.
- The incidence rate ratio (IRR) for infection, hospitalization, and mortality was significantly higher in HF patients (2.91, 4.30, and 10.60, respectively).
- Among HF patients, advanced age, male sex, prior HF hospitalizations, and comorbidities were significant risk factors for infection and mortality.
Conclusions:
- Heart failure is a significant risk factor for severe COVID-19, including increased infection, hospitalization, and mortality.
- Risk factors such as age, male sex, and disease burden (prior hospitalizations, comorbidities) necessitate targeted interventions for HF patients.
- These findings are vital for prioritizing preventive measures and informing clinical management during pandemics.
Background:
Since early reports, it has been shown that cardiovascular (CV) diseases, including heart failure (HF), represent a risk factor for infection, hospital admissions and mortality from COVID-19. The COVID-19 pandemics has been of major importance in Italy and in the Lombardy Region. Aims of this study were to compare COVID-19 infection in HF and No-HF subjects, and to quantify among HF patients the risk for COVID-19 infection and all-cause mortality.
Methods:
All consecutive patients (98,549) with at least one hospital discharge of HF (primary diagnosis) during January 1st, 2015, to December 31st, 2019, were identified in the Lombardy Region Database (>10 million inhabitants), and compared with No-HF subjects (394,104 with a lower age limit 40 years), randomly chosen in a 4:1 proportion among hospitalized patients. The whole cohort of cases of COVID-19 infection, laboratory-confirmed by RT-PCR, aged >40 years, diagnosed from the beginning of the epidemic on 21 February 2020 to 1 October 2020 was studied. The study outcomes were: occurrence, hospitalization, and death in COVID-19 cases.
Results:
Incidence of COVID-19 increased with age in both HF (p < 0.001) and No-HF patients (p < 0.001); cases (and incidence rates, IR) were 8,648 (IR = 29.653 × 100.000) in HF and 14,256 (IR = 10.195) and in No-HF (p < 0.001); hospital admissions were 4,974 (IR = 14.970) and 4,943 (IR = 3.484), respectively (p 〈0001); deaths were 7,650 (IR = 5.368) and 18,368 (IR = 56.921), respectively (p < 0.001); the incidence rate ratio (IRR) was 2.909 (95 % C.I. 2.908-2.909) for infection (p < 0.001), 4.297 (95 % C.I. 4.296-4.297) for hospital admission (p < 0.001), and 10.603 (95 % C.I.10.602-10.604) for mortality (p < 0.001). The excess IRR for mortality varied from 25.001 (95 % C.I. 24.971-25.032) for the age decade 40-49 to 1.925 (95 % C.I. 1.923-1.926) for the age decade 100-109. Among HF patients, age (OR = 1.087, 95 % C.I.1.05-1.088), male sex (OR = 1.27, 95 % C.I. 1.23-1.31), number of hospital admissions for HF during the period 2015-2019 (OR = 2.22, 95 % C.I. 2.11-2.33), co-morbidities (OR = 1.33, 95 % C.I. 1.32-1.35), or Charlson Index (OR = 1.21, 95 % C.I. 1.20-1.22), were risk factors for both infection and all-cause mortality at univariable and at multivariable analysis.
Conclusion:
Infections, hospital admissions, and mortality for COVID-19 increased with age and male sex were more frequent in HF than in No-HF patients. Among HF patients, age and sex, number of hospital admissions for HF, co-morbidities, were risk factors for both infection and mortality. These data are of relevance for prioritizing interventions for prevention of infection, and for assistance to patients with COVID-19, and to inform management of future pandemics.
More Related Videos
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management

